All In Biotech

Drug Trial Radar · NCT05919069

A Phase I Study to Investigate the Effect of Hepatic Impairment on the PK, Safety, and Tolerability of AZD2693

A Single Dose, Non-Randomised, Open-Label, Parallel Group Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of AZD2693.

Last checked: Nov 19, 2026Latest source record: May 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

35

Actual

Start

Jun 16, 2023

Primary completion

Sep 16, 2024

Study completion Sep 16, 2024

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Jun 26, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Subcutaneous administration of AZD2693 single dose in participants with hepatic impairment

Conditions

  • Hepatic Impairment

Interventions

  • AZD2693Drug

    Subcutaneous administration of AZD2693 single dose in participants with hepatic impairment

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. PK parameters AUCinfTime frame: 85 days
  2. PK parameters AUClastTime frame: 85 days
  3. PK parameters CmaxTime frame: 85 days

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Rialto, California

  • Research Site

    Miami Lakes, Florida

  • Research Site

    Orlando, Florida

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.